Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Assets Average came in at $1.0 billion in Q1 2026, up 7.66% YoY from $944.9 million in Q1 2025, and up 15.88% on a QoQ basis from $877.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Assets Average data on file, last reported at $1.0 billion in Q1 2026.
- Quarterly Assets Average rose 7.66% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 7.66% YoY) and the FY2025 annual result came in at $924.4 million, down 3.73% from the prior year.
- Assets Average improved to $1.0 billion in Q1 2026, from $877.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1.1 billion in Q4 2022 to a low of $875.2 million in Q3 2025.
- A 5-year average of $960.7 million and a median of $947.6 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average jumped 32.42% — and 2023, when it decreased 9.89%.
- Tracing TNDM's Assets Average over 5 years: stood at $1.1 billion in 2022, then dropped by 9.89% to $946.3 million in 2023, then climbed by 1.73% to $962.7 million in 2024, then fell by 8.81% to $877.9 million in 2025, then advanced by 15.88% to $1.0 billion in 2026.
- The last three Assets Average figures came in at $1.0 billion (Q1 2026), $877.9 million (Q4 2025), and $875.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 877.88 Mn |
| Sep 30, 2025 | 875.19 Mn |
| Jun 30, 2025 | 898.94 Mn |
| Mar 31, 2025 | 944.90 Mn |
| Dec 31, 2024 | 962.69 Mn |
| Sep 30, 2024 | 947.62 Mn |
| Jun 30, 2024 | 939.27 Mn |
| Mar 31, 2024 | 946.85 Mn |
| Dec 31, 2023 | 946.28 Mn |
| Sep 30, 2023 | 943.29 Mn |
| Jun 30, 2023 | 950.41 Mn |
| Mar 31, 2023 | 1.00 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 960.21 Mn |
| Dec 31, 2021 | 877.71 Mn |
| Sep 30, 2021 | 822.76 Mn |